BioInvent International receives US patent for medication discovery technology F.We.R buy online .S.T. BioInvent International Abdominal today announces that it’s been granted a US patent because of its antibody and concomitant focus on discovery technology F.We.R.S.T. Traditional drug discovery strategies involve the identification of medications applicants that bind to known disease targets. The F.I actually.R.S.T. Related StoriesCaltech experts find antibody that may detect, neutralize HIV infections in contaminated patientsBrodalumab therapy achieves 100 percent decrease in psoriasis symptomsCalcitonin-gene related peptide antibody inhibition displays migraine prevention promise BioInvent has utilized F.We.R.S.T.I.R.S.T.